Tonix Pharmaceuticals Hol... (TNXP)
NASDAQ: TNXP
· Real-Time Price · USD
51.66
-7.92 (-13.29%)
At close: Aug 15, 2025, 1:03 PM
51.23
-0.83%
After-hours: Aug 15, 2025, 04:00 PM EDT
Tonix Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 125.33M | 131.72M | 98.78M | 28.23M | 4.16M | 7.05M | 24.95M | 6.91M | 25.62M | 71.97M | 120.23M | 139.98M | 145.48M | 140.44M | 178.66M | 182.97M | 165.72M | 164.21M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | 900K | 903K | 904K | 900K | n/a | 900K | 900K | 244K | 243K | 242K | 241K | n/a | n/a | n/a | 240K | 240K | 240K | 240K |
Other Long-Term Assets | 31K | 7K | 47K | 51K | 961K | 60K | -9.51M | 1.05M | 292K | 143K | 143K | 360K | 379K | 379K | 259K | 271K | 266K | 245K |
Receivables | 7.87M | 4.83M | 7.9M | 4.01M | 3.34M | n/a | 4.59M | 1.56M | n/a | n/a | n/a | n/a | n/a | n/a | 7.73M | n/a | n/a | n/a |
Inventory | 5.99M | 8.14M | 8.41M | 7.93M | 9.46M | 12.35M | 14.15M | 13.32M | 13.7M | n/a | -8.04M | n/a | n/a | n/a | -7.73M | n/a | n/a | n/a |
Other Current Assets | 4.35M | 4.89M | 1.46M | 10.37M | 8.34M | 10.7M | 2.43M | 9.54M | 12.01M | 11.75M | 1.23M | 11.16M | 31.5M | 12.55M | 1.18M | 12.11M | 11.55M | 8.95M |
Total Current Assets | 143.53M | 149.57M | 119M | 50.54M | 25.29M | 30.1M | 47.77M | 31.34M | 51.33M | 83.73M | 130.78M | 151.14M | 191.75M | 152.99M | 189.05M | 195.08M | 177.27M | 173.16M |
Property-Plant & Equipment | 42.77M | 42.27M | 42.82M | 43.38M | 43.94M | 93.81M | 94.85M | 95.95M | 96.93M | 94.98M | 94.53M | 91.15M | 84.04M | 70.35M | 51.47M | 19.3M | 11.51M | 9.99M |
Goodwill & Intangibles | 120K | 120K | 120K | 120K | 120K | 10.47M | 10.71M | 10.95M | 11.19M | n/a | 120K | n/a | n/a | n/a | 120K | 120K | 120K | 120K |
Total Long-Term Assets | 43.82M | 43.3M | 43.89M | 44.45M | 45.02M | 105.25M | 106.69M | 107.94M | 108.41M | 95.36M | 94.91M | 91.51M | 84.42M | 70.73M | 51.85M | 19.69M | 11.9M | 10.36M |
Total Assets | 187.36M | 192.87M | 162.89M | 94.99M | 70.31M | 135.34M | 154.46M | 139.28M | 159.74M | 179.09M | 225.69M | 242.65M | 276.17M | 223.72M | 240.9M | 214.77M | 189.16M | 183.52M |
Account Payables | 7.78M | 4.19M | 4.55M | 3.94M | 10.41M | 6.65M | 3.78M | 7.8M | 7.67M | 8.02M | 8.07M | 4.56M | 9.57M | 9.4M | 13.28M | 7.96M | 3.41M | 2.86M |
Deferred Revenue | 3.01M | 1.93M | 1.82M | n/a | n/a | n/a | 2.98M | n/a | n/a | n/a | 3.27M | -504K | n/a | n/a | 2.83M | n/a | n/a | n/a |
Short-Term Debt | 195K | n/a | n/a | 2.82M | 3.1M | 2.82M | 2.35M | 434K | 436K | 438K | n/a | 504K | 511K | 397K | 489K | 583K | 464K | 386K |
Other Current Liabilities | 6.74M | 1.12M | 7.32M | 8.15M | 3.46M | n/a | 5.14M | -434K | -436K | -438K | 2.76M | -504K | -511K | -397K | 4.76M | -540K | -389K | -386K |
Total Current Liabilities | 19.06M | 12.15M | 18.31M | 15.18M | 22.04M | 20.48M | 18.88M | 17.73M | 18.44M | 13.07M | 18.18M | 13.34M | 15.91M | 15.35M | 21.72M | 12.03M | 8.08M | 6.03M |
Long-Term Debt | 297K | n/a | 4.67M | 5.17M | 5.67M | 6.16M | 6.56M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | 22.86M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 297K | 328K | 5.03M | 5.6M | 6.16M | 6.72M | 30.05M | 716K | 831K | 588K | 328K | 382K | 474K | 405K | 467K | 530K | 591K | 577K |
Total Liabilities | 19.36M | 12.47M | 23.33M | 20.78M | 28.2M | 27.2M | 48.93M | 18.45M | 19.27M | 13.66M | 18.51M | 13.72M | 47.88M | 15.76M | 22.18M | 12.56M | 8.67M | 6.61M |
Total Debt | 492K | 563K | 5.3M | 5.87M | 9.26M | 9.82M | 9.81M | 1.15M | 1.27M | 1.03M | 760K | 886K | 985K | 802K | 956K | 1.11M | 1.05M | 963K |
Common Stock | 8K | 7K | 4K | 156K | 10K | 74K | 59K | 18K | 11K | 64K | 76K | 53K | 32K | 553K | 496K | 404K | 346K | 324K |
Retained Earnings | -775.79M | -747.52M | -730.69M | -708.59M | -694.37M | -615.6M | -600.66M | -573.34M | -545.36M | -516.99M | -470.04M | -438.36M | -409.38M | -386.24M | -359.82M | -330.27M | -311.74M | -288.19M |
Comprehensive Income | -270K | -266K | -255K | -250K | -243K | -240K | -232K | -220K | -212K | -211K | -167K | -160K | -143K | -118K | -92K | -81K | -71K | -63K |
Shareholders Equity | 168M | 180.4M | 139.56M | 74.21M | 42.1M | 108.14M | 105.53M | 120.83M | 140.46M | 165.43M | 207.18M | 228.92M | 228.28M | 207.96M | 218.72M | 202.22M | 180.49M | 176.92M |
Total Investments | 900K | 903K | 904K | 900K | 902K | 900K | 900K | 244K | 243K | 242K | 241K | n/a | n/a | n/a | 240K | 240K | 240K | 240K |